Global Diabetic Neuropathy Treatment Market Size study & Forecast, and Regional Analysis, 2023-2030

by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy) by Drug Class (Capsaicin, Opioid, Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Antidepressants, Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Other) and

Published	Pages	Publisher	Report code
Apr 2024	200	Bizwit Research	ASDR-665314

Published: Apr 2024 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-665314

Pfizer Inc.
Eli Lilly and Company
Johnson & Johnson
Abbott Laboratories
Novo Nordisk A/S
Astellas Pharma Inc.
GlaxoSmithKline plc
Merck & Co. Inc.
Teva Pharmaceutical Industries Ltd.
Boehringer Ingelheim International GmbH

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020

This report can be of interest as well:

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2020

Published: July, 2020 | Report code: ASDR-559159